135.34
price down icon0.60%   -0.665
 
loading
Schlusskurs vom Vortag:
$136.01
Offen:
$135.54
24-Stunden-Volumen:
338.02K
Relative Volume:
0.05
Marktkapitalisierung:
$233.36B
Einnahmen:
$42.34B
Nettoeinkommen (Verlust:
$13.50B
KGV:
17.55
EPS:
7.71
Netto-Cashflow:
$6.66B
1W Leistung:
-2.09%
1M Leistung:
+1.21%
6M Leistung:
+19.53%
1J Leistung:
+31.00%
1-Tages-Spanne:
Value
$134.81
$136.23
1-Wochen-Bereich:
Value
$132.71
$138.84
52-Wochen-Spanne:
Value
$99.71
$140.84

Abbott Laboratories Stock (ABT) Company Profile

Name
Firmenname
Abbott Laboratories
Name
Telefon
(224) 667-6100
Name
Adresse
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Name
Mitarbeiter
114,000
Name
Twitter
@AbbottNews
Name
Nächster Verdiensttermin
2025-04-16
Name
Neueste SEC-Einreichungen
Name
ABT's Discussions on Twitter

Vergleichen Sie ABT mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
ABT
Abbott Laboratories
135.14 233.36B 42.34B 13.50B 6.66B 7.71
Medical Devices icon
BSX
Boston Scientific Corp
106.67 147.06B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
393.41 145.64B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
86.89 112.76B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
77.35 44.46B 5.54B 4.18B 623.10M 7.00

Abbott Laboratories Stock (ABT) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-16 Eingeleitet Leerink Partners Market Perform
2024-10-08 Eingeleitet Oppenheimer Outperform
2024-09-19 Eingeleitet Piper Sandler Overweight
2024-07-30 Herabstufung Edward Jones Buy → Hold
2024-05-30 Eingeleitet Goldman Buy
2023-07-21 Hochstufung Wolfe Research Underperform → Peer Perform
2023-05-30 Herabstufung Morgan Stanley Overweight → Equal-Weight
2023-04-20 Bestätigt Barclays Overweight
2023-04-20 Bestätigt Bernstein Outperform
2023-04-20 Bestätigt JP Morgan Overweight
2023-04-20 Bestätigt Raymond James Outperform
2023-04-20 Bestätigt UBS Buy
2023-04-20 Bestätigt Wolfe Research Underperform
2023-03-29 Eingeleitet UBS Buy
2022-10-26 Eingeleitet Mizuho Neutral
2022-10-18 Eingeleitet Barclays Overweight
2022-10-12 Eingeleitet Jefferies Hold
2022-07-06 Eingeleitet Wolfe Research Underperform
2022-03-02 Fortgesetzt BofA Securities Buy
2022-01-27 Bestätigt Credit Suisse Outperform
2022-01-27 Bestätigt Morgan Stanley Overweight
2022-01-27 Bestätigt Raymond James Outperform
2022-01-27 Bestätigt UBS Buy
2021-12-10 Eingeleitet RBC Capital Mkts Outperform
2021-10-27 Hochstufung Atlantic Equities Neutral → Overweight
2021-10-14 Eingeleitet Redburn Neutral
2021-05-25 Eingeleitet Barclays Overweight
2021-04-15 Eingeleitet Atlantic Equities Neutral
2021-01-28 Hochstufung BTIG Research Neutral → Buy
2020-09-11 Eingeleitet Wolfe Research Outperform
2020-06-01 Herabstufung Goldman Neutral → Sell
2020-03-05 Eingeleitet Citigroup Buy
2020-02-13 Eingeleitet Goldman Neutral
2020-02-06 Fortgesetzt BTIG Research Neutral
2020-01-02 Herabstufung Guggenheim Buy → Neutral
2019-06-13 Bestätigt BofA/Merrill Buy
2019-02-07 Bestätigt BofA/Merrill Buy
2019-01-02 Herabstufung Citigroup Neutral → Sell
2018-11-30 Hochstufung Goldman Neutral → Buy
2018-10-16 Eingeleitet Barclays Overweight
2018-06-27 Eingeleitet Bernstein Outperform
2018-01-30 Bestätigt Citigroup Neutral
2018-01-25 Bestätigt Stifel Buy
2018-01-25 Hochstufung William Blair Mkt Perform → Outperform
2018-01-03 Eingeleitet Evercore ISI Outperform
2018-01-02 Hochstufung JP Morgan Neutral → Overweight
2018-01-02 Hochstufung Morgan Stanley Equal-Weight → Overweight
2017-10-19 Bestätigt RBC Capital Mkts Outperform
2017-10-19 Bestätigt Stifel Buy
Alle ansehen

Abbott Laboratories Aktie (ABT) Neueste Nachrichten

pulisher
Jun 18, 2025

India Medical Nutrition Market Future Trends and Scope Analysis - openPR.com

Jun 18, 2025
pulisher
Jun 18, 2025

Abbott, MSD Forge Diabetes‑Drug Pact For Wider Indian Reach - BW Healthcare World

Jun 18, 2025
pulisher
Jun 18, 2025

Abbott Labs stock price target maintained at $140 by Oppenheimer - Investing.com India

Jun 18, 2025
pulisher
Jun 18, 2025

Leerink Partners Begins Coverage on ABT - Insider Monkey

Jun 18, 2025
pulisher
Jun 17, 2025

10 Best Dividend Stocks to Buy for Dependable Dividend Growth - Insider Monkey

Jun 17, 2025
pulisher
Jun 17, 2025

Who Rules Homecare Clinical Nutrition Market? Abbott, Danone, - openPR.com

Jun 17, 2025
pulisher
Jun 17, 2025

Health Canada approves Abbott’s i-STAT TBI test for suspected concussions - Medical Device Network

Jun 17, 2025
pulisher
Jun 17, 2025

Abbott, Tandem Diabetes Care Partner For Glucose-Ketone Sensor for Diabetes Management - Insider Monkey

Jun 17, 2025
pulisher
Jun 17, 2025

Abbott Laboratories (ABT): Buy, Sell, or Hold Post Q1 Earnings? - FinancialContent

Jun 17, 2025
pulisher
Jun 16, 2025

Abbott (ABT) Stock Dips While Market Gains: Key Facts - Nasdaq

Jun 16, 2025
pulisher
Jun 16, 2025

Eaton makes a move outside of the data center — plus, what's new with Abbott Labs - CNBC

Jun 16, 2025
pulisher
Jun 16, 2025

Abbott Wins Dismissal of Whistleblower’s Medicare Fraud Suit - Bloomberg Law News

Jun 16, 2025
pulisher
Jun 16, 2025

Abbott Declares 406th Consecutive Quarterly Dividend - marketscreener.com

Jun 16, 2025
pulisher
Jun 16, 2025

Abbott Laboratories' Whole Blood Concussion Test Approved by Health Canada - marketscreener.com

Jun 16, 2025
pulisher
Jun 16, 2025

Abbott Receives Health Canada Authorization for Whole Blood Rapid Test to Help Assess Suspected Concussions - Barchart.com

Jun 16, 2025
pulisher
Jun 16, 2025

Blood Screening Market Outlook | Key Players: Abbott Laboratories, Roche, Grifols, BioMérieux - openPR.com

Jun 16, 2025
pulisher
Jun 16, 2025

Deep Venous Disease Treatment Market Key Players Analysis - openPR.com

Jun 16, 2025
pulisher
Jun 16, 2025

1 Unpopular Stock that Should Get More Attention and 2 to Avoid - FinancialContent

Jun 16, 2025
pulisher
Jun 15, 2025

Jim Cramer Calls Abbott “Really Excellent” - Insider Monkey

Jun 15, 2025
pulisher
Jun 14, 2025

Electrophysiology Devices Market Share Leaders: Abbott, Acutus Medical, and Biosense Webster - openPR.com

Jun 14, 2025
pulisher
Jun 13, 2025

Abbott Laboratories (ABT) Maintains Quarterly Dividend of $0.59 - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

Abbott Declares 406Th Consecutive Quarterly Dividend, Payable on August 15, 2025 - marketscreener.com

Jun 13, 2025
pulisher
Jun 13, 2025

Piper Sandler names Abbott, Edwards, Glaukos as top medtech catalyst picks - Investing.com Nigeria

Jun 13, 2025
pulisher
Jun 13, 2025

Abbott Laboratories Keeps Quarterly Dividend at $0.59 per Share, Payable August 15 to Shareholders as of July 15 - marketscreener.com

Jun 13, 2025
pulisher
Jun 13, 2025

Clinical Immunochemistry Analyzers Market projected reach USD 6.9 billion by 2034, growing at a CAGR of 4.4% | Exactitude Consultancy - GlobeNewswire Inc.

Jun 13, 2025
pulisher
Jun 12, 2025

Abbott Laboratories Stock Sees RS Rating Rise To 82 - Investor's Business Daily

Jun 12, 2025
pulisher
Jun 12, 2025

Stocks To Watch: Abbott Laboratories Sees RS Rating Rise To 82 - MSN

Jun 12, 2025
pulisher
Jun 12, 2025

Abbott and Medtronic best positioned manufacturers in US neurology market - PharmaLive

Jun 12, 2025
pulisher
Jun 11, 2025

Abbott Laboratories (NYSE:ABT) Partners With Tandem To Develop Dual Sensor Diabetes Solutions - simplywall.st

Jun 11, 2025
pulisher
Jun 10, 2025

Tandem, Abbott team on insulin delivery with glucose-ketone sensor - MedTech Dive

Jun 10, 2025
pulisher
Jun 10, 2025

Tandem Diabetes (TNDM) Partners with Abbott for Innovative Diabe - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Tandem, Abbott in deal to combine insulin delivery with glucose-ketone sensor - Seeking Alpha

Jun 10, 2025
pulisher
Jun 10, 2025

Abbott (ABT) Partners with Tandem Diabetes for Advanced Diabetes Management Solutions | ABT Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

3 Low-Volatility Stocks in Hot Water - FinancialContent

Jun 10, 2025
pulisher
Jun 09, 2025

Abbott Laboratories Stock: Is ABT Outperforming the Health Care Sector? - MSN

Jun 09, 2025
pulisher
Jun 06, 2025

Abbott Laboratories (ABT) Stock Dips Slightly on NYSE, Long-Term Gains Remain Solid - Daily Chhattisgarh News

Jun 06, 2025
pulisher
Jun 05, 2025

Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic? - Yahoo Finance

Jun 05, 2025
pulisher
Jun 04, 2025

Thousands of lawsuits over baby formula should stay where filed, court says - Reuters

Jun 04, 2025
pulisher
Jun 04, 2025

Abbott (ABT) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance

Jun 04, 2025
pulisher
Jun 04, 2025

Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

Jun 04, 2025
pulisher
Jun 02, 2025

Test Strip Market Is Booming So Rapidly 2025-2032 -Abbott - openPR.com

Jun 02, 2025
pulisher
Jun 02, 2025

Abbott Announces FDA Approval Of Tendyne Transcatheter Mitral Valve Replacement System - insights.citeline.com

Jun 02, 2025
pulisher
Jun 02, 2025

Abbott Laboratories Stock: Is ABT Outperforming The Health Care Sector? - Barchart.com

Jun 02, 2025
pulisher
Jun 02, 2025

Goldman Sachs Adjusts Price Target on Abbott Laboratories to $153 From $147, Maintains Buy Rating - marketscreener.com

Jun 02, 2025
pulisher
Jun 01, 2025

There's Been No Shortage Of Growth Recently For Abbott Laboratories' (NYSE:ABT) Returns On Capital - Yahoo Finance

Jun 01, 2025
pulisher
May 30, 2025

Abbott Tendyne TMVR secures FDA clearance - BioWorld MedTech

May 30, 2025
pulisher
May 30, 2025

Cardiac Marker Analyzer Market Is Booming WorldwideAbbott, Roche Diagnostics - openPR.com

May 30, 2025
pulisher
May 30, 2025

Abbott Labs (ABT) Stock Ticks Lower: Gauging the Pulse and Future Price Points - Daily Chhattisgarh News

May 30, 2025

Finanzdaten der Abbott Laboratories-Aktie (ABT)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
medical_devices BSX
$106.89
price down icon 0.57%
medical_devices SYK
$393.61
price down icon 0.37%
medical_devices MDT
$86.88
price down icon 0.31%
medical_devices EW
$77.44
price down icon 0.99%
$74.06
price down icon 0.02%
Kapitalisierung:     |  Volumen (24h):